Identifying the Prevalence, Trajectory, and Determinants of Psychological Distress in Extremity Sarcoma

Table 4

Summary of DASS21, TESS, LOT-R, SSQ, SSS, and 12-month EORTC QLQ C-30 subscale scores (mean ± SD) by presence of distress at 12 months.

	Distress, = 24; (M ± SD)	No distress, = 52; (M ± SD)	Independent -test
DASS21 at baseline	33.6 ± 20.1	16.4 ± 15.2	= −3.74^**
DASS21 at 6 months	50.0 ± 26.7	13.9 ± 15.1	= −6.18^***
TESS at baseline	69.9 ± 22.9	80.9 ± 21.1	= 2.05^*
TESS at 6 months	59.9 ± 19.7	73.0 ± 17.2	= 2.95^**
TESS at 12 months	66.6 ± 15.3	81.7 ± 18.7	= 3.46^**
SSS	36.6 ± 21.7	16.8 ± 16.8	= −4.34^***
Global QoL	57.6 ± 19.6	79.2 ± 18.2	= 4.68^***
PF	66.9 ± 16.5	81.9 ± 20.4	= 3.15^**
RF	50.0 ± 33.3	80.1 ± 23.1	= 4.01^***
EF	46.9 ± 25.2	93.2 ± 10.3	= 8.67^***
CF	68.1 ± 30.3	88.1 ± 16.9	= 3.04^**
SF	43.8 ± 28.2	84.6 ± 21.4	= 6.32^***
PA	47.9 ± 31.6	17.9 ± 25.7	= −4.39^***
FI	56.9 ± 37.4	15.4 ± 20.3	= −5.11^***

^* < 0.05 (2-tailed).
^** < 0.01 (2-tailed).
^*** < 0.001 (2-tailed).